SEC Form 4 · accession 0001104659-15-085920
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aurentz Vincent
Officer — Chief Business Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2015 | P | 2,200 | $3.43 | A | 2,200 | D | |
| Common StockF1 | holding | — | — | — | 2,800 | I | Purchased by Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares were purchased by the Reporting Person's spouse for child's custodial account, for which such spouse serves as custodian.